Literature DB >> 21658772

Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases.

Benoit Faucher1, Christelle Pomares, Sabrina Fourcade, Audrey Benyamine, Pierre Marty, Laure Pratlong, Françoise Faraut, Charles Mary, Renaud Piarroux, Jean-Pierre Dedet, Francine Pratlong.   

Abstract

OBJECTIVE: Leishmania infantum mucosally restricted leishmaniasis was rarely reported, so that diagnostic and treatment strategies remain debated. A long-term multicentric survey appeared thereby necessary.
METHODS: Cases were prospectively collected over 12 years in 3 academic hospitals of Southern France. Predisposing factors, clinical findings, diagnostic procedures, treatment and outcome were compared to medical literature.
RESULTS: Ten new cases and 40 historical reports were collected. Respectively 10/10 and 35/40 patients were adult males. Immunodeficiency was frequent (5/10 and 18/40). No previous cutaneous lesion was reported. Leishmaniasis affected mostly larynx (5/10 and 19/40), but also mouth (2/10 and 19/40) and nose (3/10 and 5/40). Lesions were highly polymorph. Mucosa histological examination provided respectively 1/10 and 2/40 false negative results, contrary to serum immunoblotting and PCR on mucosal biopsy. Although local response was always satisfactory even using topical treatment, subsequent visceral spreading was observed in 2/10 and 1/40 cases.
CONCLUSION: L. infantum mucosally restricted leishmaniasis exhibits a specific pattern, marked by tropism for adult males, high clinical and histological polymorphism. Immunoblot screening and PCR confirmation of suspected lesions are necessary because of direct examination occasional false negative results. The risk of visceral spreading sustains systemic therapy.
SUMMARY: Leishmania infantum mucosal leishmaniasis mostly affects adult males, half of them immunodeficient. Clinical and histological polymorphism makes the diagnosis difficult, stressing the need for immunoblot screening and mucosa PCR analysis of suspected cases. Possible visceralization sustains systemic therapy.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658772     DOI: 10.1016/j.jinf.2011.03.012

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.

Authors:  Trupti A Patel; Glenis K Scadding; David E Phillips; Diana N Lockwood
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

Review 2.  Role of wildlife in the epidemiology of Leishmania infantum infection in Europe.

Authors:  Javier Millán; Ezio Ferroglio; Laia Solano-Gallego
Journal:  Parasitol Res       Date:  2014-05-08       Impact factor: 2.289

3.  Three Leishmania/L. species--L. infantum, L. major, L. tropica--as causative agents of mucosal leishmaniasis in Iran.

Authors:  Sadegh Shirian; Ahmad Oryan; Gholam Reza Hatam; Yahya Daneshbod
Journal:  Pathog Glob Health       Date:  2013-07       Impact factor: 2.894

4.  Molecular, cytological, and immunocytochemical study and kDNA sequencing of laryngeal Leishmania infantum infection.

Authors:  Ahmad Oryan; Sadegh Shirian; Mohammad Reza Tabandeh; Gholam Reza Hatam; Mohsen Kalantari; Yahya Daneshbod
Journal:  Parasitol Res       Date:  2012-12-24       Impact factor: 2.289

Review 5.  Mucosal leishmaniasis: an underestimated presentation of a neglected disease.

Authors:  Alessio Strazzulla; Salvatore Cocuzza; Marilia Rita Pinzone; Maria Concetta Postorino; Stefano Cosentino; Agostino Serra; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

Review 6.  Phlebotomine sand fly-borne pathogens in the Mediterranean Basin: Human leishmaniasis and phlebovirus infections.

Authors:  Martina Moriconi; Gianluca Rugna; Mattia Calzolari; Romeo Bellini; Alessandro Albieri; Paola Angelini; Roberto Cagarelli; Maria P Landini; Remi N Charrel; Stefania Varani
Journal:  PLoS Negl Trop Dis       Date:  2017-08-10

7.  Autochthonous Cases of Mucosal Leishmaniasis in Northeastern Italy: Clinical Management and Novel Treatment Approaches.

Authors:  Valeria Gaspari; Irene Zaghi; Giovanni Macrì; Annalisa Patrizi; Nunzio Salfi; Francesca Locatelli; Elena Carra; Maria Carla Re; Stefania Varani
Journal:  Microorganisms       Date:  2020-04-18

8.  Changes in the microbiological diagnosis and epidemiology of cutaneous leishmaniasis in real-time PCR era: A six-year experience in a referral center in Barcelona.

Authors:  Aroa Silgado; Mayuli Armas; Adrián Sánchez-Montalvá; Lidia Goterris; Maria Ubals; Jordi Temprana-Salvador; Gloria Aparicio; Carmen Chicharro; Núria Serre-Delcor; Berta Ferrer; Israel Molina; Vicenç García-Patos; Tomas Pumarola; Elena Sulleiro
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10

9.  Isolated laryngeal leishmaniasis in immunocompetent patients: an underdiagnosed disease.

Authors:  Salvatore Cocuzza; Alessio Strazzulla; Marilia Rita Pinzone; Stefano Cosentino; Agostino Serra; Rosario Caltabiano; Salvatore Lanzafame; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Case Rep Infect Dis       Date:  2013-04-15

10.  Heterogeneity of environments associated with transmission of visceral leishmaniasis in South-Eastern France and implication for control strategies.

Authors:  Benoit Faucher; Jean Gaudart; Francoise Faraut; Christelle Pomares; Charles Mary; Pierre Marty; Renaud Piarroux
Journal:  PLoS Negl Trop Dis       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.